Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 5 (1) , 30
Abstract
Histoplasma capsulatum is a common cause of fungal infection in certain geographic areas, and although most infections are asymptomatic, it is capable of causing histoplasmosis, a disseminated, life-threatening disease, especially in immunocompromised individuals. A deeper understanding of this host-pathogen interaction is needed to develop novel therapeutic strategies to counter lethal infection. Although several lines of evidence suggest that this fungus is neurotropic in HIV patients, little is known about the immunobiology of Histoplasma infection in the central nervous system [CNS]. The goal of the present study was to understand the innate neuroimmune mechanisms that recognize H. capsulatum during the initial stages of infection. Using a 293T stable cell line expressing murine Toll-like receptor 2 [TLR2], we show here that TLR2 recognizes H. capsulatum cell wall protein Yps3p and induces the activation of NF-κB. In further experiments, we tested the ability of Yps3p to induce signaling from TLR2 in primary microglial cells, the resident brain macrophages of the CNS. Our data show that H. capsulatum Yps3p induced TLR2 signaling in wild-type microglia, but not in microglia isolated from TLR2 KO mice, confirming that Yps3p is a ligand for TLR2. Furthermore, Yps3p-induced TLR2 signaling was suppressed by vaccinia virus-encoded TLR inhibitors. This is the first demonstration of a fungal protein serving as a TLR ligand and mediating signaling in primary brain cells.Keywords
This publication has 45 references indexed in Scilit:
- Toll-like Receptor (TLR) Signaling in Response toAspergillus fumigatusJournal of Biological Chemistry, 2002
- Saccharomyces cerevisiae‐ and Candida albicans‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent MannerMicrobiology and Immunology, 2002
- Antifungal Therapy for Central Nervous System Histoplasmosis, Using a Newly Developed Intracranial Model of InfectionThe Journal of Infectious Diseases, 2002
- The Role of Toll‐like Receptor (TLR) 2 and TLR4 in the Host Defense against Disseminated CandidiasisThe Journal of Infectious Diseases, 2002
- A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signalingProceedings of the National Academy of Sciences, 2000
- Amphotericin B Combined with Itraconazole or Fluconazole for Treatment of HistoplasmosisThe Journal of Infectious Diseases, 2000
- Cerebellar and medullar histoplasmosis.2000
- Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty‐first centuryTransplant Infectious Disease, 1999
- A case of HIV-associated cerebral histoplasmosis successfully treated with fluconazole.European Journal of Clinical Microbiology & Infectious Diseases, 1999
- Central Nervous System Histoplasmosis Mimicking a Brain Tumor: Difficulties in Diagnosis and TreatmentMayo Clinic Proceedings, 1999